Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Drug Resistant Epilepsy × Cannabidiol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Sturge-Weber Syndrome 1 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Multiple Myeloma 1 Liver Neoplasms 1 Glioblastoma 1 Gallbladder Neoplasms 1 Drug Resistant Epilepsy 1 Colonic Neoplasms 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02332655 2022-03-02

Cannabidiol Expanded Access Study in Medically Refractory Sturge-Weber Syndrome

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Phase 1/2 Completed

5 enrolled 8 charts

Drug Resistant Epilepsy, Sturge-Weber Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡